Literature DB >> 22079085

The "untreatability" of psychopathy and hospital commitment in the USA.

Alan R Felthous1.   

Abstract

One argument in support of a public policy of not subjecting persons with psychopathic disorders to civil or criminal commitment is that these disorders do not improve with treatment. This article examines the relationship between the assumption of untreatability of psychopathic disorders and outpatient civil commitment, inpatient civil commitment, and insanity acquittee commitment. Research on the treatability of psychopathy is reviewed and the treatment of conditions co-morbid with psychopathy is considered. Research evidence is insufficient to support the conclusion that psychopathy is improved, worsened or not affected by treatment. Evidence does support effective treatments for conditions that can be co-morbid with psychopathic disorders including impulsive aggression which can be interpreted as a manifestation of psychopathic disorder. The absence of evidence based treatment efficacy for psychopathic disorders is a logical reason for not subjecting individuals with only a psychopathic disorder to involuntary hospitalization. This assumption should not becloud the possibility of treatable co-morbid conditions which may or may not qualify for involuntary hospitalization. Where the primary mental disorder, for which an individual is involuntarily hospitalized, results in behavioral improvement, the continued presence of a psychopathic disorder itself, should not be sufficient reason to continue coerced confinement. Even so, where the primary disorder is incompletely treated, psychopathy can be considered a risk factor when deciding upon the appropriate time for discharge and when formulating a safe and effective after care plan.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22079085     DOI: 10.1016/j.ijlp.2011.10.004

Source DB:  PubMed          Journal:  Int J Law Psychiatry        ISSN: 0160-2527


  2 in total

1.  Management of ADHD in Prisoners-Evidence Gaps and Reasons for Caution.

Authors:  John Tully
Journal:  Front Psychiatry       Date:  2022-03-18       Impact factor: 4.157

2.  Amygdala GluN2B-NMDAR dysfunction is critical in abnormal aggression of neurodevelopmental origin induced by St8sia2 deficiency.

Authors:  Alexandre Bacq; Simone Astori; Elias Gebara; Wei Tang; Bianca A Silva; Jose Sanchez-Mut; Jocelyn Grosse; Isabelle Guillot de Suduiraut; Olivia Zanoletti; Catherine Maclachlan; Graham W Knott; Johannes Gräff; Carmen Sandi
Journal:  Mol Psychiatry       Date:  2018-08-08       Impact factor: 15.992

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.